Publications

  1. Martin CE, Kohorst MA, Ferdjallah A, Kalmes JL, Johnson HM, Galardy PJ, Khan SP, Kuhn AK. Symptomatic hyperammonemia secondary to recombinant Erwinia asparaginase. Pediatr Blood Cancer 2023 May; 70 (5):e30208 Epub 2023 Jan 12
    View PubMed
  2. Woods EJ, Walker LE, Heaton HA, Scanlan-Hanson LN, Finley JL, Olson OJ, Khan SP, Mannenbach MS. Improving Timely Antibiotic Administration for Pediatric Oncology Patients With Neutropenic Fever Seen in the Emergency Department. Mayo Clin Proc Innov Qual Outcomes. 2022 Dec; 6 (6):597-604 Epub 2022 Nov 05
    View PubMed
  3. Martin ES, Ferrer A, Mangaonkar AA, Khan SP, Kohorst MA, Joshi AY, Hogan WJ, Olteanu H, Moyer AM, Al-Kali A, Tefferi A, Chen D, Wudhikarn K, Go R, Viswanatha D, He R, Ketterling R, Nguyen PL, Oliveira JL, Gangat N, Lasho T, Patnaik MM. Spectrum of hematological malignancies, clonal evolution and outcomes in 144 Mayo Clinic patients with germline predisposition syndromes. Am J Hematol. 2021 Nov 1; 96 (11):1450-1460 Epub 2021 Aug 27
    View PubMed
  4. Mangaonkar AA, Ferrer A, Vairo FPE, Hammel CW, Prochnow C, Gangat N, Hogan WJ, Litzow MR, Peters SG, Scott JP, Utz JP, Baqir M, Carmona-Porquera EM, Kalra S, Sekiguchi H, Khan SP, Simonetto DA, Klee EW, Kamath PS, Roden AC, Joshi AY, Kennedy CC, Wylam ME, Patnaik MM. Clinical and molecular correlates from a predominantly adult cohort of patients with short telomere lengths. Blood Cancer J 2021 Oct 22; 11 (10):170
    View PubMed
  5. DiFilippo EC, Coltro G, Carr RM, Mangaonkar AA, Binder M, Khan SP, Rodriguez V, Gangat N, Wolanskyj A, Pruthi RK, Chen D, He R, Viswanatha DS, Lasho T, Finke C, Tefferi A, Pardanani A, Patnaik MM. Spectrum of abnormalities and clonal transformation in germline RUNX1 familial platelet disorder and a genomic comparative analysis with somatic RUNX1 mutations in MDS/MPN overlap neoplasms. Leukemia 2020 Sep; 34 (9):2519-2524 Epub 2020 Feb 14
    View PubMed
  6. Anagnostou T, Knudson RA, Pearce KE, Meyer RG, Pitel BA, Peterson JF, Baughn LB, Reichard KK, Ketterling RP, Kloft-Nelson SM, Knutson DL, Khan SP, Gangat N, Litzow MR, Hogan WJ, Wolanskyj A, Al-Kali A, Begna KH, Elliott M, Pardanani A, Foran J, Shah M, Tefferi A, Alkhateeb H, Halling K, Rodriguez V, Greipp PT, Patnaik MM. Clinical utility of fluorescence in situ hybridization-based diagnosis of BCR-ABL1 like (Philadelphia chromosome like) B-acute lymphoblastic leukemia. Am J Hematol 2020 Mar; 95 (3):E68-E72 Epub 2020 Jan 26
    View PubMed
  7. Schaller A, Myers A, Khan S, Joshi A, Rodriguez V, Maher G. Case 4: Thrombocytopenia and Hematochezia in an Infant. Pediatr Rev. 2019 May; 40 (5):254-255
    View PubMed
  8. Cupit-Link MC, Nageswara Rao A, Warad DM, Rodriguez V, Khan S, Khan S. EBV-PTLD, Adenovirus, and CMV in Pediatric Allogeneic Transplants With Alemtuzumab as Part of Pretransplant Conditioning: A Retrospective Single Center Study. J Pediatr Hematol Oncol. 2018 Nov; 40 (8):e473-e478
    View PubMed
  9. McThenia SS, Rawwas J, Oliveira JL, Khan SP, Rodriguez V. Hepatosplenic gammadelta T-cell lymphoma of two adolescents: Case report and retrospective literature review in children, adolescents, and young adults. Pediatr Transplant. 2018 Aug; 22 (5):e13213 Epub 2018 June 19
    View PubMed
  10. Mangaonkar AA, Ferrer A, Pinto E Vairo F, Cousin MA, Kuisle RJ, Klee EW, Kennedy CC, Peters SG, Scott JP, Utz JP, Baqir M, Sekiguchi H, Khan SP, Rodriguez V, Simonetto DA, Kamath PS, Abraham RS, Wylam ME, Patnaik MM. Clinical Correlates and Treatment Outcomes for Patients With Short Telomere Syndromes. Mayo Clin Proc. 2018 Jul; 93 (7):834-839
    View PubMed
  11. Perez Botero J, Ho TP, Hogan WJ, Kenderian S, Gangat N, Tefferi A, Abraham RS, Nguyen P, Oliveira JL, He R, Chen D, Viswanatha D, Rodriguez V, Khan SP, Patnaik MM. Clinical spectrum and clonal evolution in germline syndromes with predisposition to myeloid neoplasms. Br J Haematol. 2018 Jul; 182 (1):141-145 Epub 2017 May 09
    View PubMed
  12. Kaur D, Ashrani AA, Pruthi R, Khan SP, Bailey K, Rodriguez V. Thrombotic and hemorrhagic complications in children and young adult recipients of Hematopoietic Stem Cell Transplant (HSCT). Thromb Res. 2018 Jul; 167:44-49 Epub 2018 Apr 26
    View PubMed
  13. Kaur D, Khan SP, Rodriguez V, Arndt C, Claus P. Hyperbaric oxygen as a treatment modality in cyclophosphamide-induced hemorrhagic cystitis. Pediatr Transplant. 2018 Jun; 22 (4):e13171 Epub 2018 Mar 23
    View PubMed
  14. Bata BM, Pulido JS, Patel SV, Khan SP, Salomao D, Boyce TG, Bothun ED. Combined intraocular and systemic rituximab for ocular lymphoproliferative disorder with extranodal marginal zone lymphoma-type morphology after heart transplant. J AAPOS. 2018 Apr; 22 (2):159-161 Epub 2018 Apr 03
    View PubMed
  15. Wyatt KD, Cooper J, Scott K, Broomall E, Altaf S, Hogan MC, Rodriguez V, Khan S, Khan S. Delayed Methotrexate Clearance Despite Carboxypeptidase-G2 (Glucarpidase) Administration in 2 Patients With Toxic Methotrexate Levels. J Pediatr Hematol Oncol. 2018 Mar; 40 (2):152-155
    View PubMed
  16. Dorn JM, Abraham RS, Rodriguez V, Khan SP, Stefanski H, Joshi A. Optimal approach to assessing T-cell function in haematopoietic cell transplant recipients. BMJ Case Rep. 2018 Jan 23; 2018
    View PubMed
  17. Qureshi MY, Cabalka AK, Khan SP, Hagler DJ, Haile DT, Cannon BC, Olson TM, Cantero-Peral S, Dietz AB, Radel DJ, Taggart NW, Kelle AM, Rodriguez V, Dearani JA, O'Leary PW, Wanek Program Regenerative Medicine Pipeline. Cell-Based Therapy for Myocardial Dysfunction After Fontan Operation in Hypoplastic Left Heart Syndrome. Mayo Clin Proc Innov Qual Outcomes. 2017 Sep; 1 (2):185-191 Epub 2017 Aug 02
    View PubMed
  18. Schmitt AR, Wetter DA, Camilleri MJ, Khan SP, Tollefson MM. Langerhans cell histiocytosis presenting as a blueberry muffin rash. Lancet. 2017 Jul 8; 390 (10090):155 Epub 2017 May 04
    View PubMed
  19. Hartono S, Motosue MS, Khan S, Rodriguez V, Iyer VN, Divekar R, Joshi AY. Predictors of granulomatous lymphocytic interstitial lung disease in common variable immunodeficiency. Ann Allergy Asthma Immunol. 2017 May; 118 (5):614-620 Epub 2017 Feb 20
    View PubMed
  20. Lee SJ, Logan B, Westervelt P, Cutler C, Woolfrey A, Khan SP, Waller EK, Maziarz RT, Wu J, Shaw BE, Confer D, Horowitz MM, Anasetti C. Comparison of Patient-Reported Outcomes in 5-Year Survivors Who Received Bone Marrow vs Peripheral Blood Unrelated Donor Transplantation: Long-term Follow-up of a Randomized Clinical Trial. JAMA Oncol. 2016 Dec 1; 2 (12):1583-1589
    View PubMed
  21. Barba P, Burns LJ, Litzow MR, Juckett MB, Komanduri KV, Lee SJ, Devlin SM, Costa LJ, Khan S, King A, Klein A, Krishnan A, Malone A, Mir M, Moravec C, Selby G, Roy V, Cochran M, Stricherz MK, Westmoreland MD, Perales MA, Wood WA. Success of an International Learning Health Care System in Hematopoietic Cell Transplantation: The American Society of Blood and Marrow Transplantation Clinical Case Forum. Biol Blood Marrow Transplant. 2016 Mar; 22 (3):564-570 Epub 2015 Dec 21
    View PubMed
  22. Bidadi B, Nageswara Rao AA, Kaur D, Khan SP, Rodriguez V. Neonatal renal vein thrombosis: role of anticoagulation and thrombolysis--an institutional review. Pediatr Hematol Oncol. 2016 Feb; 33: (1)59-66.
    View PubMed
  23. Fabian CJ, Meyskens FL Jr, Bajorin DF, George TJ Jr, Jeter JM, Khan S, Tyne CA, William WN Jr. Barriers to a Career Focus in Cancer Prevention: A Report and Initial Recommendations From the American Society of Clinical Oncology Cancer Prevention Workforce Pipeline Work Group. J Clin Oncol. 2016 Jan 10; 34 (2):186-93 Epub 2015 Nov 02
    View PubMed
  24. Schmelkin LA, Howard MT, Steensma DP, Fleming MD, Rodriguez V, Khan S, Gangat N, Wolanskyj A, Patnaik MM. Clinico-pathological features and outcomes in patients with congenital sideroblastic anemias Blood. 2015 Dec 3; 126(23):3355. Epub 1900 Jan 01.
  25. Bidadi B, Uzodi AS, Pritt BS, Khan SP, Henry NK. Adolescent With Lymphadenopathy in the Absence of Systemic Symptoms. Clin Pediatr (Phila). 2015 Oct; 54: (12)1221-3.
    View PubMed
  26. Rao AA, Rao AA, Gourde JA, Marri P, Galardy PJ, Khan SP, Rodriguez V. Congenital amegakaryocytic thrombocytopenia: a case report of pediatric twins undergoing matched unrelated bone marrow transplantation. J Pediatr Hematol Oncol. 2015 May; 37 (4):304-6
    View PubMed
  27. Rodriguez V, Wylam ME, Khan SP, Gourde J, Anderson PM. Successful treatment of pulmonary graft versus host disease with aerosolized cyclosporine Open Journal of Clinical & Medical Case Reports.2015;1:(1):
  28. Kumar R, Rodriguez V, Matsumoto JM, Khan SP, Weaver AL, McBane RD, Beebe TJ, Heit JA. Prevalence and risk factors for post thrombotic syndrome after deep vein thrombosis in children: a cohort study. Thromb Res. 2015 Feb; 135(2):347-51. Epub 2014 Dec 05.
    View PubMed
  29. Warad D, Kohorst MA, Altaf S, Ishitani MB, Khan S, Rodriguez V, Nageswara Rao AA. Acute appendicitis in acute leukemia and the potential role of decitabine in the critically ill patient. Leuk Res Rep. 2015; 4 (1):21-3 Epub 2015 Mar 18
    View PubMed
  30. Kumar R, Rodriguez V, Matsumoto JM, Khan SP, Weaver AL, McBane RD, Beebe TJ, Heit JA. Health-related quality of life in children and young adults with post-thrombotic syndrome: results from a cross-sectional study. Pediatr Blood Cancer. 2014 Mar; 61(3):546-51.
    View PubMed
  31. Ruparel RK, Bogert JN, Moir CR, Ishitani MB, Khan SP, Rodriguez V, Zarroug AE. Synchronous splenectomy during cholecystectomy for hereditary spherocytosis: is it really necessary? J Pediatr Surg. 2014 Mar; 49 (3):433-5
    View PubMed
  32. Marsh RA, Allen CE, McClain KL, Weinstein JL, Kanter J, Skiles J, Lee ND, Khan SP, Lawrence J, Mo JQ, Bleesing JJ, Filipovich AH, Jordan MB. Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab. Pediatr Blood Cancer. 2013 Jan; 60(1):101-9. Epub 2012 Apr 22.
    View PubMed
  33. Anasetti C, Logan BR, Lee SJ, Waller EK, Weisdorf DJ, Wingard JR, Cutler CS, Westervelt P, Woolfrey A, Couban S, Ehninger G, Johnston L, Maziarz RT, Pulsipher MA, Porter DL, Mineishi S, McCarty JM, Khan SP, Anderlini P, Bensinger WI, Leitman SF, Rowley SD, Bredeson C, Carter SL, Horowitz MM, Confer DL, Blood and Marrow Transplant Clinical Trials Network. Peripheral-blood stem cells versus bone marrow from unrelated donors. N Engl J Med. 2012 Oct 18; 367(16):1487-96.
    View PubMed
  34. Khan S, Juckett MB, Komanduri KV, Krishnan A, Burns LJ, American Society of Blood and Marrow Transplantation Committee on Education. American Society of Blood and Marrow Transplantation Guidelines for Training in Hematopoietic Progenitor Cell Transplantation. Biol Blood Marrow Transplant. 2012 Sep; 18(9):1322-8. Epub 2012 Apr 19.
    View PubMed
  35. Nageswara Rao, Kumar R, Altaf S, Gourde JA, Rodriguez V, Khan SP. Pretransplant conditioning with Campath-1H (alemtuzumab) in pediatric matched unrelated hematopoietic stem cell transplants: an institutional experience. J Pediatr Hematol Oncol. 2012 Mar; 34(2):96-100.
    View PubMed
  36. Joshi AY, Ham EK, Shah NB, Dong X, Khan SP, Abraham RS. Atypical Omenn Syndrome due to Adenosine Deaminase Deficiency. Case Reports Immunol. 2012; 2012:919241 Epub 2012 May 31
    View PubMed
  37. Kumar R, Galardy PJ, Dogan A, Rodriguez V, Khan SP. Rituximab in combination with multiagent chemotherapy for pediatric follicular lymphoma. Pediatr Blood Cancer. 2011 Aug; 57(2):317-20. Epub 2011 Apr 01.
    View PubMed
  38. Oliveira JL, Kumar R, Khan SP, Law ME, Erickson-Johnson M, Oliveira AM, Ketterling RP, Dogan A. Successful treatment of a child with T/myeloid acute bilineal leukemia associated with TLX3/BCL11B fusion and 9q deletion. Pediatr Blood Cancer. 2011 Mar; 56(3):467-9. Epub 2010 Nov 11.
    View PubMed
  39. Kumar R, Khan SP, Joshi DD, Shaw GR, Ketterling RP, Feldman AL. Pediatric histiocytic sarcoma clonally related to precursor B-cell acute lymphoblastic leukemia with homozygous deletion of CDKN2A encoding p16INK4A. Pediatr Blood Cancer. 2011 Feb; 56(2):307-10.
    View PubMed
  40. Kumar R, Rodriguez V, Khan SP, Laack N, Arndt CA. Post Radiation Dermatofibrosarcoma Protuberans in a Patient with Wilms tumor. Journal of pediatric hematology Oncology. 2011.
  41. Horn B, Soni S, Khan S, Petrovic A, Breslin N, Cowan M, Pelle-Day G, Cooperstein E, Baxter-Lowe LA. Feasibility study of preemptive withdrawal of immunosuppression based on chimerism testing in children undergoing myeloablative allogeneic transplantation for hematologic malignancies. Bone Marrow Transplant. 2009 Mar; 43(6):469-76. Epub 2008 Oct 27.
    View PubMed
  42. Renaud DL, Khan S. Development of a multidisciplinary programme for the treatment of X-linked adrenoleukodystrophy. Paediatr. Child Health (CAN). 2009; 19: (Suppl 2)S217-9.
  43. Sabapathy C, Gourde JA, Khan SP, Rodriguez V. Tacrolimus with mini-methotrexate as prophylaxis for graft-versus-host disease in pediatric patients after allogeneic peripheral blood stem cell transplant or bone marrow transplant. J Pediatr Hematol Oncol. 2008 Dec; 30(12):945-9.
    View PubMed
  44. Frangoul H, Nemecek ER, Billheimer D, Pulsipher MA, Khan S, Woolfrey A, Manes B, Cole C, Walters MC, Ayas M, Ravindranath Y, Levine JE, Grupp SA. A prospective study of G-CSF primed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium (PBMTC) study. Blood. 2007 Dec 15; 110(13):4584-7 Epub 2007 Sep 7.
    View PubMed
  45. Rodriguez V, Anderson PM, Trotz BA, Arndt CA, Allen JA, Khan SP. Use of infliximab-daclizumab combination for the treatment of acute and chronic graft-versus-host disease of the liver and gut. Pediatr Blood Cancer. 2007 Aug; 49 (2):212-5
    View PubMed
  46. Kennedy-Nasser AA, Leung KS, Mahajan A, Weiss HL, Arce JA, Gottschalk S, Carrum G, Khan SP, Heslop HE, Brenner MK, Bollard CM, Krance RA. Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia. Biol Blood Marrow Transplant. 2006 Dec; 12(12):1277-84.
    View PubMed
  47. Deeg HJ, O'Donnell M, Tolar J, Agarwal R, Harris RE, Feig SA, Territo MC, Collins RH, McSweeney PA, Copelan EA, Khan SP, Woolfrey A, Storer B. Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. Blood. 2006 Sep 1; 108(5):1485-91. Epub 2006 May 09.
    View PubMed
  48. Rodriguez V, Anderson PM, Litzow MR, Erlandson L, Trotz BA, Arndt CA, Khan SP, Wiseman GA. Marrow irradiation with high-dose 153Samarium-EDTMP followed by chemotherapy and hematopoietic stem cell infusion for acute myelogenous leukemia. Leuk Lymphoma. 2006 Aug; 47 (8):1583-92
    View PubMed
  49. Imran H, Tleyjeh IM, Zirakzadeh A, Rodriguez V, Khan SP. Use of prophylactic anticoagulation and the risk of hepatic veno-occlusive disease in patients undergoing hematopoietic stem cell transplantation: a systematic review and meta-analysis. Bone Marrow Transplant. 2006 Apr; 37 (7):677-86
    View PubMed
  50. Rodriguez V, Khan SP. Late graft rejection following allogeneic bone marrow transplantation in aplastic anemia. Transplant Proc. 2002 Jun; 34 (4):1307-9
    View PubMed
  51. Rodriguez V, Kuehnle I, Heslop HE, Khan S, Krance RA. Guillain-Barre syndrome after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2002 Mar; 29(6):515-7.
    View PubMed
  52. Mhawech P, Buffone GJ, Khan SP, Gresik MV. Cytochemical staining and flow cytometry methods Applied to the diagnosis of acute leukemia in the pediatric population: an assesment of relative usefulness. Journal of Pediatric Hematology/Oncology. 2001; 23(2):89-92.
  53. Deeg HJ, Amylon ID, Harris RE, Collins R, Beatty PG, Feig S, Ramsay N, Territo M, Khan SP, Pamphilon D, Leis JF, Burdach S, Anasetti C, Hackman R, Storer B, Mueller B. Marrow transplants from unrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation. Biol Blood Marrow Transplant. 2001; 7(4):208-15.
    View PubMed
  54. Heslop H, Rooney C, Brenner M, Krance R, Carrum G, Gahn B, Bollard C, Khan S, Gee A, Popat U, Gresik M, Przepiorka D, Kuehnle I, Grilley B. Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease. Hum Gene Ther. 2000; 11:1465-75.
    View PubMed
  55. Seber A, Khan SP, Kersey JH. Unexplained effusions: association with allogeneic BMT and acute or chronic GVHD. Bone marrow Transplantation. 1996; 17:207-11.
    View PubMed
  56. Davies SM, Khan SP, Wagner JE, Arthur DC, Auerbach AD, Ramsay NKC, Weisdorf DJ. Unrelated donor Bone marrow transplantation for fanconi anemia. Bone Marrow Transplantation. 1996; 17:43- 47.
    View PubMed
  57. Khan SP, Gilchrist GS, Arndt CA, Smithson WA, Chen MG, Schomberg PJ, Matsumoto JM, O'Fallon WM. Vancouver hybrid: preliminary experience in the treatment of Hodgkin's disease in childhood and adolescence. Mayo Clin Proc. 1994 Oct; 69 (10):949-54
    View PubMed
  58. Khan SP, Raza A, Yousuf N, Barcos M, Saikia T, Masterson M, Bennett J, Browman G, Goldberg J, Grunwald H, Larson R, Sandberg A, Vogler R, Priesler HD. Cell cycle and clinical characteristics of patients with myeloproliferative disorders whose biopsies are reactive with anti-factor VIII antibody : a leukemia inter-group study. Leukemia Research. 1991; 15:51-7.
    View PubMed
  59. Raza A, Khan SP, Mehdi I, Imren S, Yasin Z, Priesler HD. Cell cycle characteristics in Myeloid leukemias. Bone Marrow Transplantation Vol 4 suppl. 1989; 1:26-9.
  60. Raza A, Maheshwari Y, Mandava N, Yasin Z, Perveen S, Mayers G, Goldberg J, Gottlieb A, Grunwald H, Larson R, Miller K, Vogler R, Priesler HD. Cell cycle and drug sensitivity studies of leukemic cells that appear relevant in determining response to chemotherapy in acute nonlymphocytic leukemia. Sem Oncol 14 Suppl. 1987; 1:217-25.